NO20082938L - Formuleringer av quinolinoner - Google Patents
Formuleringer av quinolinonerInfo
- Publication number
- NO20082938L NO20082938L NO20082938A NO20082938A NO20082938L NO 20082938 L NO20082938 L NO 20082938L NO 20082938 A NO20082938 A NO 20082938A NO 20082938 A NO20082938 A NO 20082938A NO 20082938 L NO20082938 L NO 20082938L
- Authority
- NO
- Norway
- Prior art keywords
- compound
- quinolinones
- formulations
- tautomer
- salt
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 title 1
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical class C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 title 1
- 229930185107 quinolinone Natural products 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 abstract 1
- 229920002472 Starch Polymers 0.000 abstract 1
- 239000001913 cellulose Substances 0.000 abstract 1
- 229920002678 cellulose Polymers 0.000 abstract 1
- 229960000913 crospovidone Drugs 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
- 235000019359 magnesium stearate Nutrition 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 abstract 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 abstract 1
- 239000000377 silicon dioxide Substances 0.000 abstract 1
- 235000012239 silicon dioxide Nutrition 0.000 abstract 1
- 239000008107 starch Substances 0.000 abstract 1
- 235000019698 starch Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74057705P | 2005-11-29 | 2005-11-29 | |
| US74131705P | 2005-12-01 | 2005-12-01 | |
| PCT/US2006/045711 WO2007064719A2 (en) | 2005-11-29 | 2006-11-29 | Formulations of quinolinones |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20082938L true NO20082938L (no) | 2008-06-30 |
Family
ID=38024178
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20082938A NO20082938L (no) | 2005-11-29 | 2008-06-30 | Formuleringer av quinolinoner |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US20080293738A1 (de) |
| EP (2) | EP2772257A1 (de) |
| JP (1) | JP2009517481A (de) |
| KR (1) | KR20080074143A (de) |
| CN (1) | CN102670530A (de) |
| AR (1) | AR062545A1 (de) |
| AU (1) | AU2006320591B2 (de) |
| BR (1) | BRPI0619370A2 (de) |
| CA (1) | CA2627544C (de) |
| CL (1) | CL2010000387A1 (de) |
| EC (1) | ECSP088467A (de) |
| ES (1) | ES2467162T3 (de) |
| IL (1) | IL190865A0 (de) |
| MA (1) | MA29969B1 (de) |
| MY (1) | MY148529A (de) |
| NO (1) | NO20082938L (de) |
| NZ (1) | NZ567550A (de) |
| PE (1) | PE20070760A1 (de) |
| PL (1) | PL1957074T3 (de) |
| PT (1) | PT1957074E (de) |
| RU (1) | RU2433826C2 (de) |
| TW (1) | TW200730176A (de) |
| WO (1) | WO2007064719A2 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20091628A1 (es) * | 2008-03-19 | 2009-11-19 | Novartis Ag | Formas cristalinas y dos formas solvatadas de sales de acido lactico de 4-amino-5-fluoro-3-[5-(4-metilpiperazin-1-il)-1h-benzimidazol-2-il]quinolin-2(1h)-ona |
| KR20160129109A (ko) | 2008-05-23 | 2016-11-08 | 아미라 파마슈티칼스 인코포레이티드 | 5-리폭시게나아제 활성화 단백질 억제제 |
| PT2309987E (pt) * | 2008-07-03 | 2012-12-13 | Novartis Ag | Processo para granulação por fusão |
| UY33472A (es) * | 2010-06-30 | 2012-01-31 | Novartis Ag | ?composiciones farmacéuticas que comprenden monohidrato de lactato de 4-amino-5-fluoro-3-[6-(4-metil-piperazin-1-il)-1hbencimidazol-2-il]-1h-quinolin-2-ona?. |
| WO2013063003A1 (en) | 2011-10-28 | 2013-05-02 | Novartis Ag | Method of treating gastrointestinal stromal tumors |
| EP2809312A1 (de) | 2012-01-31 | 2014-12-10 | Novartis AG | Kombination eines rtk-inhibitors mit einem anti-östrogen und verwendung davon zur behandlung von krebs |
| IN2014DN10801A (de) | 2012-07-11 | 2015-09-04 | Novartis Ag | |
| WO2014058785A1 (en) | 2012-10-10 | 2014-04-17 | Novartis Ag | Combination therapy |
| TWI535784B (zh) | 2014-08-26 | 2016-06-01 | 財團法人工業技術研究院 | 剪切增稠配方、及包含其之複合材料 |
| JP7469308B2 (ja) | 2018-12-06 | 2024-04-16 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッド | 新規の医薬製剤 |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3663606A (en) * | 1966-06-21 | 1972-05-16 | Mitsui Toatsu Chemicals | Organic imino-compounds |
| DE2363459A1 (de) | 1973-12-20 | 1975-06-26 | Basf Ag | Neue fluoreszierende chinolinverbindungen |
| US4119105A (en) | 1977-01-31 | 1978-10-10 | Olin Corporation | Air flow limiting filter |
| JPH0699497B2 (ja) | 1987-04-16 | 1994-12-07 | 富士写真フイルム株式会社 | 光重合性組成物 |
| GB9108547D0 (en) | 1991-04-22 | 1991-06-05 | Fujisawa Pharmaceutical Co | Quinoline derivatives |
| US5480883A (en) * | 1991-05-10 | 1996-01-02 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase |
| JP3161780B2 (ja) | 1991-09-30 | 2001-04-25 | 東レ・ダウコーニング・シリコーン株式会社 | α，ω−ジヒドロキシフルオロアルキルメチルポリシロキサンの製造方法 |
| JP3142378B2 (ja) | 1992-06-22 | 2001-03-07 | ティーディーケイ株式会社 | 有機ｅｌ素子 |
| US5763441A (en) | 1992-11-13 | 1998-06-09 | Sugen, Inc. | Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| JPH0743896A (ja) | 1993-07-28 | 1995-02-14 | Toyobo Co Ltd | 光重合性組成物 |
| JPH0829973A (ja) | 1994-07-11 | 1996-02-02 | Toyobo Co Ltd | 光重合性組成物 |
| JP3441246B2 (ja) | 1995-06-07 | 2003-08-25 | 富士写真フイルム株式会社 | 光重合性組成物 |
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| US6010711A (en) * | 1996-01-26 | 2000-01-04 | University Of Rochester | Methods, articles and compositions for the pharmacologic inhibition of bone resorption with phosphodiesterase inhibitors |
| EP0888310B1 (de) | 1996-03-15 | 2005-09-07 | AstraZeneca AB | Cinoline derivate und verwendung als heilmittel |
| DE19610723A1 (de) | 1996-03-19 | 1997-09-25 | Bayer Ag | Elektrolumineszierende Anordnungen unter Verwendung von Blendsystemen |
| KR20000022040A (ko) | 1996-06-20 | 2000-04-25 | 보오드 오브 리젠츠, 더 유니버시티 오브 텍사스 시스템 | 약학적 활성 제제를 제공하기 위한 화합물, 방법 및 그의 용도 |
| IL128994A (en) | 1996-09-25 | 2004-12-15 | Zeneca Ltd | History of quinoline and naphthyridine and their salts, processes for their preparation, pharmaceutical preparations containing them and their use as medicines |
| US20030027818A1 (en) * | 2001-04-03 | 2003-02-06 | Redmond H. Paul | Treatment of cancers |
| GB9716557D0 (en) * | 1997-08-06 | 1997-10-08 | Glaxo Group Ltd | Benzylidene-1,3-dihydro-indol-2-one derivatives having anti-cancer activity |
| DE69838172T2 (de) | 1997-08-22 | 2008-04-10 | Astrazeneca Ab | Oxindolylchinazolinderivate als angiogenesehemmer |
| AU3850299A (en) | 1998-05-20 | 1999-12-06 | Kyowa Hakko Kogyo Co. Ltd. | Vegf activity inhibitors |
| US6138605A (en) | 1998-08-05 | 2000-10-31 | Seascape Systems Limited | Access and evacuation apparatus with articulated arm |
| DE19841985A1 (de) | 1998-09-03 | 2000-03-09 | Schering Ag | Dialkylsulfonsäure- und Dialkylcarbonsäure-Derivate |
| IL126953A0 (en) | 1998-11-08 | 1999-09-22 | Yeda Res & Dev | Pharmaceutical compositions comprising porphyrins and some novel porphyrin derivatives |
| PE20010306A1 (es) | 1999-07-02 | 2001-03-29 | Agouron Pharma | Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa |
| YU54202A (sh) | 2000-01-18 | 2006-01-16 | Agouron Pharmaceuticals Inc. | Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije |
| EP1248642A4 (de) | 2000-01-18 | 2005-05-18 | Ludwig Inst Cancer Res | Peptidomimetischer inhibitor von vegf sowie vegf-c und -d |
| CN1307303C (zh) | 2000-01-19 | 2007-03-28 | 帕卡什·S·吉尔 | 针对反义vegf寡核苷酸的方法和组合物 |
| GB0001930D0 (en) | 2000-01-27 | 2000-03-22 | Novartis Ag | Organic compounds |
| ES2357474T3 (es) * | 2000-03-07 | 2011-04-26 | Rush-Presbyterian-St.Luke's Medical Center | Composiciones y su uso para atrapar e inactivar microbios patógenos y espermatoziodes. |
| AU2001293233A1 (en) | 2000-09-01 | 2002-03-13 | Chiron Corporation | Aza heterocyclic derivatives and their therapeutic use |
| US20030028018A1 (en) | 2000-09-11 | 2003-02-06 | Chiron Coporation | Quinolinone derivatives |
| EP1650203B1 (de) | 2000-09-11 | 2008-02-20 | Novartis Vaccines and Diagnostics, Inc. | Verfahren zur Herstellung von Benzimidazol-2-yl -Chinolinonderivaten |
| US6476068B1 (en) * | 2001-12-06 | 2002-11-05 | Pharmacia Italia, S.P.A. | Platinum derivative pharmaceutical formulations |
| AU2003288899B2 (en) | 2002-08-23 | 2009-09-03 | Novartis Vaccines And Diagnostics, Inc. | Benzimidazole quinolinones and uses thereof |
| US7825132B2 (en) * | 2002-08-23 | 2010-11-02 | Novartis Vaccines And Diagnostics, Inc. | Inhibition of FGFR3 and treatment of multiple myeloma |
| BR0316229A (pt) * | 2002-11-13 | 2005-10-04 | Chiron Corp | Métodos de tratamento de câncer e métodos relacionados |
| JP4890255B2 (ja) * | 2003-11-07 | 2012-03-07 | ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド | 改良された薬物特性を有するキノリノン化合物の薬学的に受容可能な塩 |
| JP5019884B2 (ja) * | 2004-02-20 | 2012-09-05 | ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド | 炎症プロセスおよび転移プロセスの調節 |
| WO2006122950A1 (en) * | 2005-05-18 | 2006-11-23 | M & G Polimeri Italia S.P.A. | Polyester composition |
| WO2006127926A2 (en) * | 2005-05-23 | 2006-11-30 | Novartis Ag | Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactic acid salts |
-
2006
- 2006-11-29 MY MYPI20081687A patent/MY148529A/en unknown
- 2006-11-29 AR ARP060105279A patent/AR062545A1/es unknown
- 2006-11-29 NZ NZ567550A patent/NZ567550A/en not_active IP Right Cessation
- 2006-11-29 EP EP14150490.2A patent/EP2772257A1/de not_active Withdrawn
- 2006-11-29 CN CN2012100464971A patent/CN102670530A/zh active Pending
- 2006-11-29 CA CA2627544A patent/CA2627544C/en not_active Expired - Fee Related
- 2006-11-29 BR BRPI0619370-6A patent/BRPI0619370A2/pt not_active IP Right Cessation
- 2006-11-29 RU RU2008126384/15A patent/RU2433826C2/ru not_active IP Right Cessation
- 2006-11-29 TW TW095144180A patent/TW200730176A/zh unknown
- 2006-11-29 PT PT68385905T patent/PT1957074E/pt unknown
- 2006-11-29 EP EP06838590.5A patent/EP1957074B1/de active Active
- 2006-11-29 WO PCT/US2006/045711 patent/WO2007064719A2/en active Application Filing
- 2006-11-29 KR KR1020087012826A patent/KR20080074143A/ko not_active Application Discontinuation
- 2006-11-29 PE PE2006001517A patent/PE20070760A1/es not_active Application Discontinuation
- 2006-11-29 ES ES06838590.5T patent/ES2467162T3/es active Active
- 2006-11-29 JP JP2008543426A patent/JP2009517481A/ja active Pending
- 2006-11-29 US US12/094,806 patent/US20080293738A1/en not_active Abandoned
- 2006-11-29 AU AU2006320591A patent/AU2006320591B2/en not_active Ceased
- 2006-11-29 PL PL06838590T patent/PL1957074T3/pl unknown
-
2008
- 2008-04-14 IL IL190865A patent/IL190865A0/en unknown
- 2008-05-20 MA MA30953A patent/MA29969B1/fr unknown
- 2008-05-23 EC EC2008008467A patent/ECSP088467A/es unknown
- 2008-06-30 NO NO20082938A patent/NO20082938L/no not_active Application Discontinuation
-
2010
- 2010-04-19 CL CL2010000387A patent/CL2010000387A1/es unknown
-
2012
- 2012-07-05 US US13/542,216 patent/US20120276200A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| IL190865A0 (en) | 2008-11-03 |
| MA29969B1 (fr) | 2008-11-03 |
| AU2006320591A1 (en) | 2007-06-07 |
| CL2010000387A1 (es) | 2010-08-06 |
| TW200730176A (en) | 2007-08-16 |
| EP2772257A1 (de) | 2014-09-03 |
| CA2627544C (en) | 2015-07-07 |
| PL1957074T3 (pl) | 2014-08-29 |
| MY148529A (en) | 2013-04-30 |
| US20080293738A1 (en) | 2008-11-27 |
| ECSP088467A (es) | 2008-06-30 |
| US20120276200A1 (en) | 2012-11-01 |
| ES2467162T3 (es) | 2014-06-12 |
| CN102670530A (zh) | 2012-09-19 |
| BRPI0619370A2 (pt) | 2011-09-27 |
| WO2007064719A3 (en) | 2007-08-16 |
| NZ567550A (en) | 2011-08-26 |
| EP1957074A2 (de) | 2008-08-20 |
| WO2007064719A2 (en) | 2007-06-07 |
| PT1957074E (pt) | 2014-06-25 |
| RU2433826C2 (ru) | 2011-11-20 |
| EP1957074B1 (de) | 2014-03-19 |
| PE20070760A1 (es) | 2007-10-04 |
| JP2009517481A (ja) | 2009-04-30 |
| AU2006320591B2 (en) | 2010-06-03 |
| KR20080074143A (ko) | 2008-08-12 |
| CA2627544A1 (en) | 2007-06-07 |
| RU2008126384A (ru) | 2010-01-10 |
| AR062545A1 (es) | 2008-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20082938L (no) | Formuleringer av quinolinoner | |
| WO2007087548A3 (en) | Chemical compounds | |
| NO20092033L (no) | Nye forbindelser | |
| NO20072978L (no) | Nye betuinderivater, preparat derav og anvendelse derav | |
| NO20066055L (no) | Pyridinderivater | |
| NO20070224L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
| SE0400284D0 (sv) | Novel compounds | |
| WO2006096444A3 (en) | Chemical compounds | |
| WO2004085385A3 (en) | Cannabinoid receptor ligands | |
| NO20073720L (no) | Heterocyklisk substituerte fenylmetanoner som inhibitorer av glycintransportorer | |
| NO20050828L (no) | lndol-3-svovelderivater | |
| NO20070564L (no) | Kinoliner uten tiazolinonsubstituenter. | |
| NO20092286L (no) | Nitrogenhaldige heterosykliske forbindelser og anvendelse derav | |
| NO20062491L (no) | Benzoksazinderivter og deres anvendelse | |
| ATE512961T1 (de) | Amorphes nebivolol hydrochlorid und seine herstellung | |
| NO20063748L (no) | Kinolinderivater og anvendelse derav som mykobakterielle inhibitorer | |
| NO20081844L (no) | Terapeutiske forbindelser | |
| WO2003082205A3 (en) | Compounds and methods | |
| NO20052074L (no) | Substituerte benzoksazinoner og anvendelser derav. | |
| NO20072963L (no) | 5-substituerte kinolin- og isokinolinderivater, fremgangsmate for deres fremstilling og deres anvendelse som betennelseshemmere | |
| NO20090346L (no) | Pyrazolderivater som inhibitorer av cytokrom P450 | |
| NO20054787D0 (no) | Indenderivater som farmasotiske midler | |
| NO20082265L (no) | Dispergerbare tabletter som innbefatter deferasirox | |
| NO20072939L (no) | Makroloner - aminosubstituerte kinoloner | |
| NO20081001L (no) | Derivater av karboksamid som antagonister for muskarinisk reseptor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |